106 related articles for article (PubMed ID: 3475205)
1. Acute lymphoblastic leukemia of childhood monitored by bacteriocin and flowcytometry.
Musclow CE; Farkas-Himsley H; Weitzman SS; Herridge M
Eur J Cancer Clin Oncol; 1987 Apr; 23(4):411-8. PubMed ID: 3475205
[TBL] [Abstract][Full Text] [Related]
2. Bacteriocin and flow cytometry in laboratory diagnosis of leukemic peripheral blood lymphocytes and bone marrow cells.
Musclow E; Farkas-Himsley H
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):163-71. PubMed ID: 6572148
[TBL] [Abstract][Full Text] [Related]
3. Reactivity of acute lymphoblastic leukemia and normal bone marrow cells with the monoclonal anti-B-lymphocyte antibody, anti-Y 29/55.
Hirt A; Baumgartner C; Forster HK; Imbach P; Wagner HP
Cancer Res; 1983 Sep; 43(9):4483-5. PubMed ID: 6603266
[TBL] [Abstract][Full Text] [Related]
4. Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.
Borella L; Sen L; Casper JT
J Immunol; 1977 Jan; 118(1):309-15. PubMed ID: 318669
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of antihuman thymocyte serum with acute leukemic blasts.
Mills B; Sen L; Borella L
J Immunol; 1975 Oct; 115(4):1038-44. PubMed ID: 1100719
[TBL] [Abstract][Full Text] [Related]
6. Immunological detection of residual leukaemic disease in the bone marrow of children with acute lymphoblastic leukaemia.
Kumar S; Carr TF; Hann IM; Jones PH; Evans DI
Br Med J; 1978 Mar; 1(6112):544-6. PubMed ID: 272943
[TBL] [Abstract][Full Text] [Related]
7. Definition of the high-risk acute lymphoblastic leukemia patient by immunological phenotyping with monoclonal antibodies.
Zipf TF; Fox RI; Dilley J; Levy R
Cancer Res; 1981 Nov; 41(11 Pt 2):4786-9. PubMed ID: 6975160
[TBL] [Abstract][Full Text] [Related]
8. Detection of residual acute lymphoblastic leukemia cells in cultures of bone marrow obtained during remission.
Estrov Z; Grunberger T; Dubé ID; Wang YP; Freedman MH
N Engl J Med; 1986 Aug; 315(9):538-42. PubMed ID: 3488505
[TBL] [Abstract][Full Text] [Related]
9. Phagocytic activity and expression of myeloid-associated cell surface antigens by blast cells in acute lymphoblastic leukemia.
Pui CH; Mirro J; Woodruff L; Motroni T; Stass S
Med Pediatr Oncol; 1986; 14(1):12-6. PubMed ID: 2419741
[TBL] [Abstract][Full Text] [Related]
10. Immunologic and clinicopathologic features of common acute lymphoblastic leukemia antigen-positive childhood T-cell leukemia. A Pediatric Oncology Group Study.
Dowell BL; Borowitz MJ; Boyett JM; Pullen DJ; Crist WM; Quddus FF; Russell EC; Falletta JM; Metzgar RS
Cancer; 1987 Jun; 59(12):2020-6. PubMed ID: 2952260
[TBL] [Abstract][Full Text] [Related]
11. Contribution of immunological markers to the diagnosis and prognosis of human leukemia.
von Fliedner V
Eur J Cancer Clin Oncol; 1985 Mar; 21(3):347-53. PubMed ID: 3159579
[TBL] [Abstract][Full Text] [Related]
12. Cell surface markers in acute lymphoblastic leukemia.
Humphrey GB; Blackstock R; Filler J
Ann Clin Lab Sci; 1980; 10(3):169-80. PubMed ID: 6967278
[TBL] [Abstract][Full Text] [Related]
13. A case of hand mirror cell variant of acute lymphoblastic leukemia.
Lai M; Hamasaki K; Tokioka M; Tsubota T; Nakata Y; Kitajima K; Kimura I; Sanada H
Acta Med Okayama; 1980 Sep; 34(4):283-7. PubMed ID: 6452031
[TBL] [Abstract][Full Text] [Related]
14. Immunodiagnosis of childhood ALL with monoclonal antibodies to myeloid and lymphoid associated antigens.
Dinndorf PA; Benjamin D; Ridgway D; Bernstein ID
Leuk Res; 1985; 9(4):449-61. PubMed ID: 3889508
[TBL] [Abstract][Full Text] [Related]
15. Utility of monoclonal antibodies in the immunologic phenotyping of acute lymphoblastic leukemia.
Yu AL; Royston I; Leung KL; Kung FH; Hartman GA; Lightsey AL; Vangrove J; Sobol RE
Hybridoma; 1982; 1(2):91-8. PubMed ID: 6985381
[TBL] [Abstract][Full Text] [Related]
16. Haemoglobin and prognosis in childhood acute lymphoblastic leukaemia.
Hann IM; Scarffe JH; Palmer MK; Evans DI; Jones PH
Arch Dis Child; 1981 Sep; 56(9):684-6. PubMed ID: 6945824
[TBL] [Abstract][Full Text] [Related]
17. Persistence of bone marrow lymphocytosis after induction treatment in common acute lymphoblastic leukemia. Marker analysis and significance.
Ifrah N; Boucheix C; Marie JP; Innes J; Perrot JY; Rio B; Cadiou M; Zittoun R
Cancer; 1986 Nov; 58(9):2018-22. PubMed ID: 3463396
[TBL] [Abstract][Full Text] [Related]
18. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
19. Early relapse of acute lymphoblastic leukemia is not predictable by serial biochemical assays of terminal transferase activity in cells from peripheral blood.
Barr RD; Koekebakker M; Sarin PS
Leuk Res; 1984; 8(3):351-4. PubMed ID: 6589454
[TBL] [Abstract][Full Text] [Related]
20. Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Uckun FM; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman GH; Gaynon PS
Clin Cancer Res; 2000 Aug; 6(8):3123-30. PubMed ID: 10955793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
